Literature DB >> 11271907

Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.

I W Birchall1, Z Lalani, P Venner, J Hugh.   

Abstract

Haemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11271907     DOI： 10.1259/bjr.73.874.11271907

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  5 in total

1.  The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation.

Authors:  Małgorzata Poręba; Paweł Gać; Lidia Usnarska-Zubkiewicz; Witold Pilecki; Kazimierz Kuliczkowski; Grzegorz Mazur; Małgorzata Sobieszczańska; Rafał Poręba
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-01-24       Impact factor: 1.468

2.  Cyclophosphamide-induced Atrial Fibrillation With Rapid Ventricular Rate.

Authors:  Komal Ejaz; Muhammad A Raza; Shahram Maroof; Muhammad W Haider
Journal:  Cureus       Date:  2018-05-16

Review 3.  Acute Cyclophosphamide Hemorrhagic Myopericarditis: Dilemma Case Report, Literature Review and Proposed Diagnostic Criteria.

Authors:  Subeer Wadia
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management.

Authors:  Sumandeep Dhesi; Michael P Chu; Gregg Blevins; Ian Paterson; Loree Larratt; Gavin Y Oudit; Daniel H Kim
Journal:  J Investig Med High Impact Case Rep       Date:  2013-01-01

5.  Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis.

Authors:  Yayoi Sato-Okabayashi; Kikuo Isoda; Beate Heissig; Tomoyasu Kadoguchi; Koji Akita; Kenichi Kitamura; Kazunori Shimada; Koichi Hattori; Hiroyuki Daida
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.